Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
5.57
-0.29 (-4.95%)
At close: Nov 20, 2026, 4:00 PM EST
5.60
+0.03 (0.54%)
After-hours: Nov 20, 2026, 7:30 PM EST
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.23 billion as of November 20, 2026. It is the 8,477th most valuable company in the world and the 2,031st biggest in the United States. Its market cap has decreased by 52.46% in one year.
Market Cap
1.23B
Enterprise Value
774.93M
1-Year Change
-52.46%
Global Rank
Country Rank
#2,031 United States
Category
ChartMarket Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.23B, an increase of 353.06%. That is a compound annual growth rate of 13.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.23B | -52.62% |
| Dec 31, 2025 | 2.59B | 92.64% |
| Dec 31, 2024 | 1.34B | 279.05% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
| Jul 25, 2014 (IPO) | 270.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.30B |
| Avalyn Pharma | 1.26B |
| LB Pharmaceuticals | 1.26B |
| MannKind | 1.24B |
| Novavax | 1.23B |
| Silence Therapeutics | 1.23B |
| Generate Biomedicines | 1.23B |
| Taysha Gene Therapies | 1.21B |